Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 2YS34 | — |
administered an expired dose of Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 8-year-old male patient who received HAV (Havrix) (batch number 2YS34, expiry date 02-MAR-2025) for prophylaxis. Previously administered products included Havrix (Received 1st dose of vaccine on 27-AUG-2024 (Lot number 423NL and expiration date 16 November 2025 )). On 04-MAR-2025, the patient received the 2nd dose of Havrix. On 04-MAR-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administered an expired dose of Havrix). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-MAR-2025 Medical assistant reported that they accidentally administered an expired dose of Havrix on 04 March 2025 which led to expired vaccine administered. The dose was expired on 02 March 2025. The patient got a first dose of Havrix on 27 August 2024. Consented to follow up.